Use of real world evidence to support FDA approval of oncology drugs

Value in Health

8 October 2020 - Real world evidence has gained increased attention in recent years as a complement to traditional clinical trials. 

The use of RWE to establish the efficacy of oncology drugs for FDA approval has not been described. 

In this paper, Feinberg et al. review 5 recent examples where real world evidence was submitted in support of the FDA approvals of original or supplementary indications for oncology drugs.

Read Value in Health article

Michael Wonder

Posted by:

Michael Wonder